Portal de Periódicos da CAPES

The role of the basophil in allergic inflammation

1995; Wiley; Volume: 50; Issue: 6 Linguagem: Inglês

10.1111/j.1398-9995.1995.tb01180.x

1398-9995

John T. Schroeder, Anne Kagey‐Sobotka, Lawrence M. Lichtenstein,

Allergic Rhinitis and Sensitization

AllergyVolume 50, Issue 6 p. 463-472 Free Access The role of the basophil in allergic inflammation J. T. Schroeder, J. T. Schroeder Johns Hopkins University School of Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USASearch for more papers by this authorA. Kagey-Sobotka, A. Kagey-Sobotka Johns Hopkins University School of Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USASearch for more papers by this authorL. M. Lichtenstein, Corresponding Author L. M. Lichtenstein Johns Hopkins University School of Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USADr Lawrence M. Lichtenstein Johns Hopkins Asthma and Allergy Center 5501 Hopkins Bayview Circle Baltimore, MD 21224 USA.Search for more papers by this author J. T. Schroeder, J. T. Schroeder Johns Hopkins University School of Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USASearch for more papers by this authorA. Kagey-Sobotka, A. Kagey-Sobotka Johns Hopkins University School of Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USASearch for more papers by this authorL. M. Lichtenstein, Corresponding Author L. M. Lichtenstein Johns Hopkins University School of Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USADr Lawrence M. Lichtenstein Johns Hopkins Asthma and Allergy Center 5501 Hopkins Bayview Circle Baltimore, MD 21224 USA.Search for more papers by this author First published: June 1995 https://doi.org/10.1111/j.1398-9995.1995.tb01180.xCitations: 63AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Abehsira-Amar, O, Gilbert, M, Jolly, M, Theze, J, Jankovic, DTLj. IL-4 plays a dominant role in the differential development of th0 into Th1 and Th2 cells. J Immunol 1992: 148: 3820–9. 2 Akagi, K, Townley, RG. Spontaneous histamine release and histamine content in normal subjects and subjects with asthma. J Allergy Clin Immunol 1989: 83: 742–9. 3 Alam, R, Forsythe, PA, Lett-Brown, MA, Grant, JA. Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells. J Immunol 1989: 142: 3951–6. 4 Alam, R, Welter, JB, Forsythe, PA, Lett-Brown, MA, Grant, JA. Comparative effects of recombinant IL-1, -2, -3. -4 and -6, IFN-γ, granulocyte-macrophage-colony stimulating factor, tumor necrosis factor-α, and histamine-releasing factor on the secretion of histamine from basophils. J Immunol 1989: 142: 3431–5. 5 Arock, M, Mearle-Beral, H, Dugas, B, et al. IL-4 release by human leukemic and activated normal basophils. J Immunol 1993: 151: 1441–7. 6 Bascom, R, Pipkorn, U, Lichtenstein, LM, Naclerio, RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Am Rev Respir Dis 1988: 138: 406–12. 7 Bascom, R, Wachs, M, Naclerio, RM, Pipkorn, U, Galli, SJ, Lichtenstein, LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pre-treatment. J Allergy Clin Immunol 1988: 81: 580–9. 8 Baumgarten, CR, Nichols, RC, Naclerio, RM, Proud, D. Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol 1986: 137: 1323–8. 9 Ben-Sasson, SZ, Le Gros, G, Conrad, DH, Finkelman, FD, Paul, WE. Cross-linking Fc receptors stimulates splenic non-B, non-T cells to secrete interleukin-4 and other lymphokines. Proc Natl Acad Sci U S A 1989: 87: 1421–5. 10 Bischoff, SC, De Weckal, Dahinden, CA. Interleukin-3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component c3a. Proc Natl Acad Sci U S A 1990: 87: 6813–17. 11 Bischoff, SC, Brunner, T, De Weck, AL, Dahinden, CA. Interleukin-5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 1990: 172: 1577–82. 12 Bochner, BS, Charles Worth, EN, Lichtenstein, LM, et al. Interleukin-1 is released at sites of cutaneous allergic reactions. J Allergy Clin Immunol 1990: 86: 830–9. 13 Bochner, BS, Lichtenstein, LM. Mechanisms of basophil recruitment in allergic diseases. Clin Exp Allergy 1992: 22: 975. 14 Bochner, BS, McKelvey, AA, Sterbinsky, S, et al. IL-3 augments adhesiveness for endothelium and CD1 Ib expression in human basophils but not neutrophils. J Immunol 1990: 145: 1832–7. 15 Brindley, LL, Sweet, JM, Goetzl, EJ. Stimulation of histamine release from human basophils by human platelet factor 4. J Clin Invest 1983: 72: 1218–23. 16 Brown, MA, Pierce, JH, Watson, CJ, Falco, J, Ihle, JN, Paul, WE. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 1987: 50: 809–18. 17 Brunner, T, Heusser, CH, Dahinden, CA. Human peripheral blood basophils primed by interleukin-3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993: 177: 605–11. 18 Burnet, FM. The probable relationship of some or all mast cells to the T-cell system. Cell Immunol 1977: 30: 358–60. 19 Casolaro, V, Spadaro, G, Marone, G. Human basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis 1990: 142: 1108–11. 20 Charlesworth, EN, Hood, AF, Soter, NA, Kagey-Sobotka, A, Norman, PS, Lichtenstein, LM. Cutaneous late-phase response to allergen: mediator release and inflammatory cell infiltration. J Clin Invest 1989: 83: 1519–26. 21 Charlesworth, EN, Kagey-Sobotka, A, Schleimer, RP, Norman, PS, Lichtenstein, LM. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to antigen. J Immunol 1990: 146: 671–6. 22 Charlesworth, EN, Massey, WA, Kagey-Sobotka, A, Norman, PS, Lichtenstein, LM. Effect of H, receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992: 262: 964–70. 23 Chung, SW, Wong, PMC, Shen-Ong, G, Ruscetti, S, Ishizaka, T, Eaves, CJ. production of granulocyte-macrophage colony-stimulating factor by Abelson virus-induced tumorigenic mast cell lines. Blood 1986: 68: 1074–81. 24 Cohan, VL, Undem, BJ, Fox, CC, Adkinson, NF Jr, Lichtenstein, LM, Schleimer, RP. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. Am Rev Respir Dis 1989: 140: 951–4. 25 Collins, JV, Wardlaw, AJ, Cromwell, O, Kay, AB. Mast cells and neutrophils in bronchoalveolar lavage from asthmatics. J Allergy Clin Immunol 1986: 77 (Suppl.): 209. 26 Columbo, M, Casolaro, V, Warner, JA, Macglashan, DW JR, Kagey-Sobotka, A, Lichtenstein, LM. The mechanism of mediator release from human basophils induced by platelet-activating factor. J Immunol 1990: 145: 3855–61. 27 Columbo, M, Horowitz, EM, Botana, LM, et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992: 149: 599–608. 28 Conrad, DH, Bensasson, SZ, Le Gros, G, Finkelman, FD, Paul, WE. Infection with Nippostrongylus brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin-4 production by non-B, non-T cells. J Exp Med 1990: 171: 1497–1508. 29 Czarnetzkl, BM, Sterry, W, Bazin, H, Kalveram, KJ. Evidence that tissue mast cells derive from mononuclear phagocytes. Int Arch Appl Immunol 1982: 67: 44–8. 30 Dahinden, CA, Geiser, T, Brunner, T, et al. Monocyte chemotactic protein 3 is a most effective basophil and eosinophil-activating chemokine. J Exp Med 1994: 179: 751–6. 31 Del Prete, G, Maggi, E, Parronchi, P, et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988: 140: 4193–8. 32 Dunsky, EH, Zweiman, B. The direct demonstration of histamine release in the skin using a skin chamber technique. J Allergy Clin Immunol 1978: 62: 127–30. 33 Dvorak, AM. Morphologic and immunologic characterization of human basophils (1879–1985). J Immunol Immu-nopharmacol 1988: 8: 50–83. 34 Findlay, SR, Lichtenstein, LM. Basophil "releasability" in patients with asthma. Am Rev Respir Dis 1980: 122: 53–9. 35 Flint, KC, Leung, KBP, Hudspith, BN, Brostoff, J, Pearce, FL, Johnson, NM. bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. BMJ 1985: 291: 923–6. 36 Fox, CC, Dvorak, AM, Peters, SP, Kagey-Sobotka, A, Lichtenstein, LM. Isolation and characterization of human intestinal mucosal mast cells. J Immunol 1985: 135: 483–91. 37 Gaddy, JN, Busse, WW. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma. Am Rev Respir Dis 1986: 134: 969–74. 38 Gagnon, R, Akoum, A, Hebert, J. Lol p I-induced IL-4 and IFN-γ production by peripheral blood mononuclear cells of atopic and nonatopic subjects during and out of the pollen season. J Allergy Clin Immunol 1993: 91: 950–6. 39 Galli, SJ, Lichtenstein, LM. Biology of mast cells and basophils. In: E Middleton, CE Reed, EF Ellis, NF Adkinson, JW Yunginger, Eds. Allergy: principles and practice. St Louis , MO : CV Mosby, 1988: 106–34. 40 Gibson, PG, Dolovich, J, Girgis-Gabardo, A, et al. The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils, and their progenitors. Clin Exp Allergy 1990: 20: 661–8. 41 Gibson, PG, Manning, PJ, O'Byrne, PM, et al. Allergen-induced asthmatic responses: relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils. And their progenitors. Am Rev Respir Dis 1991: 143: 331–5. 42 Glovsky, MM, Hugli, TE, Ishizaka, T, Lichtenstein, LM, Erikson, BW. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. J Clin Invest 1979: 64: 804–11. 43 Gleich, GJ. The late phase of the immunoglobulin E-mediated reactions: a link between anaphylaxis and common allergic disease J Allergy Clin Immunol 1982: 70: 160–9. 44 Grant, JA, Alam, R, Lett-Brown, MA. Histamine-releasing factors and inhibitors. Historical perspectives and possible implications in human illness. J Allergy Clin Immunol 1991: 88: 683–93. 45 Guo, C-B, Liu, MC, Galli, SJ, Bochner, BS, KageySobotka, A, Lichtenstein, LM. Identification of IgE-bearing cells in the late phase response to antigen in the lung as basophils. Am J Respir Cell Mol Biol 1993: 10: 384–90. 46 Guydon, LD, Kagey-Sobotka, A, Lichtenstein, LM, et al. Relationships between peripheral blood basophil releasability and lung physiology following antigen challenge in asthma. Am J Respir Crit Care Med 1994: 149: A962. 47 Hirai, K, Morita, Y, Misaki, Y, et al. Modulation of human basophil histamine release by hematopoietic growth factors. J Immunol 1988: 141: 3957–64. 48 Hirai, K, Yamaguchi, M, Misaki, Y, et al. Enhancement of human basophil histamine release by interleukin-5. J Exp Med 1990: 172: 1525–8. 49 Iliopoulos, O, Baroody, F, Naclerio, RM, Bochner, BS, Kagey-Sobotka, A, Lichtenstein, LM. Histamine containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 1992: 148: 2223–8. 50 Ishizaka, T, Debernardo, R, Tomioka, H, Lichtenstein, LM, Ishizaka, K. Identification of basophil granulocytes as a site of allergic histamine release. J Immunol 1972: 108: 1000–4. 51 Lawrence, ID, Warner, JA, Cohan, VL, Hubbard, WC, Kagey-Sobotka, A, Lichtenstein, LM. Purification and characterization of human skin mast cells: evidence for human mast cell heterogeneity. J Immunol 1987: 139: 3062–9. 52 Liu, MC, Bleecker, ER, Lichtenstein, LM, et al. Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airway of subjects with mild asthma. Am Rev Respir Dis 1990: 142: 126–32. 53 Liu, MC, Hubbard, WC, Proud, D, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in asthmatics: cellular, mediator and permeability changes. Am Rev Respir Dis 1991: 144: 51–8. 54 Kagey-Sobotka, A, Macdonald, SM, Fox, C, Warner, JA, Lichtenstein, LM. In vitro and in vivo studies of human basophils and mast cells: mediators, secretogogues, and pharmacology. In: Proceedings of the First Capri Conference on Clinical Immunology. Toronto : BC Decker. 1989: 39–47. 55 Kaplan, AP, Haak-Frendscho, M, Fauci, A, Dinarello, C, Halbert, E. A Histamine releasing factor from activated human mononuclear cells. J Immunol 1985: 135: 2027–32. 56 Kauffman, F, Neukirch, F, Annesi, I, Korobaeff, M, Dore, M-F, Lellouch, J. Relation of perceived nasal and bronchial hyperresponsiveness to FEV, basophil counts, and methacholine response. Thorax 1988: 43: 456–61. 57 Kirloy, JG, Hargreave, FE, Gleich, GJ, O'Byrne, PM. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987: 136: 379–83. 58 Kirshenbaum, AS, Goff, JP, Kessler, SW, Mican, JM, Zsebo, KM, Metcalfe, DD. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34 + pluripotent progenitor cells. J Immunol 1992: 148: 772–7. 59 Koshino, T, Teshima, S, Fukushima, N, et al. Identification of basophils by immunohistochemistry in the airways of postmortem cases of fatal asthma. Clin Exp Allergy 1993: 23: 919–25. 60 Kuna, P, Reddigari, SR, Schall, TJ, Rucinski, D, Sadick, M, Kaplan, AP. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol 1993: 150: 1932–43. 61 Le Gros, G, BenSasson, SZ, Conrad, DH, et al. IL-3 promotes production of IL-4 by splenic non-B, non-T cells in response to Fc receptor cross-linkage. J Immunol 1990: 145: 2500–6. 62 Lichtenstein, LM, Norman, PS, Winkenwerder, WL. Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever. Am J Med 1968: 44: 514–24. 63 Liu, MC, Proud, D, Lichtenstein, LM, et al. Human lung macrophage-derived histamine releasing activity is due to an IgE-binding factor(s). J Immunol 1986: 136: 2588–95. 64 MacDonald, SM, Lichtenstein, LM, Proud, D, et al. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol 1987: 139: 506–12. 65 MacDonald, SM, Schleimer, RP, Kagey-Sobotka, A, Gillis, S, Lichtenstein, LM. Recombinant IL-3 induces histamine release from human basophils. J Immunol 1989: 142: 3527–32. 66 MacGlashan, DW JR, Botana, L. Biphasic Ca ++ responses in human basophils: evidence that the initial transient elevation associated with mobilization of intracellular calcium is an insufficient signal for degranulation. J Immunol 1993: 150: 980–91. 67 MacGlashan, DW JR, Warner, JA. Stimulus-dependent leukotriene release from human basophils: a comparative study of C5a and Fmet-leu-phe. J Leukoc Biology 1991: 49: 29–40. 68 MacGlashan, DW JR, White, JM, Huang, S-K, Ono, SJ, Schroeder, JT, Lichtenstein, LM. Secretion of interleukin-4 from human basophils: the relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol 1993: 152: 3006–16. 69 Massey, WA, Friedman, B, Kato, M, et al. Appearance of IL-3 and GM-CSF activity at allergen-challenged cutaneous late-phase reaction sites. J Immunol 1993: 150: 1084–92. 70 Massey, W, Guo, CB, Dvorak, AM, et al. Human uterine mast cells: isolation, purification, characterization, ultra-structure and pharmacology. J Immunol 1991: 47: 1621–7. 71 Massey, WA, Kato, M, Bochner, BS, et al. Inhibition of late phase reaction areas, inflammatory cell appearance, and local cytokine production by topical steroid treatment in a cutaneous model of allergic inflammation. J Allergy Clin Immunol (Submitted). 72 Massey, WA, Randall, TC, Kagey-Sobotka, A, et al. Recombinant human IL-1-alpha and -1-beta potentiate IgE-mediated histamine release from human basophils. J Immunol 1989: 142: 1875–80. 73 Moser, R, Fehr, J. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol 1992: 149: 1432–8. 74 Mossman, TR, Cherwinski, H, Bond, MW, Giedlin, MA, Coffman, RL. Two types of murine helper T-cell clones. I. Definition according to profiles of lymphokine activities and secreted protein. J Immunol 1986: 136: 2348–57. 75 Naclerio, RM, Proud, D, Togias, AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985: 313: 65–70. 76 Nguyen, KL, Gillis, S, Macglashan, DW Jr. A comparative study of releasing and nonreleasing human basophils: nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking. J Allergy Clin Immunol 1990: 85: 1020–9. 77 Okuda, M, Ohtsuka, H. Basophilic cells in allergic nasal secretions. Arch Otorhinolaryngol 1977: 214: 283–9. 78 Orchard, MA, Kagey-Sobotka, A, Proud, D, Lichtenstein, LM. Basophil histamine release induced by a substance from stimulated human platelets. J Immunol 1986: 136: 2240–4. 79 Parkin, JL, McKenna, RW, Brunning, RD. Ultrastructural features of basophil and mast cell granulopoiesis in blastic phase Philadelphia chromosome positive leukemia. J Natl Cancer Inst 1980: 65: 534–46. 80 Paul, WE, Seder, RA, Plaut, M. Lymphokine and cytokine production by fcɛRI positive cells. Adv Immunol 1993: 53: 1–29. 81 Pepys, J, Davies, RJ, Breslin, ABX, Hendrick, DJ, Hutchcroft, BJ. The effect of inhaled beclomethasone dipropionate (Becotide) and sodium cromoglycate on asthmatic reaction to provocation tests. Clin Allergy 1974: 4: 13–24. 82 Piccinni, M-P, Macchia, D, Parronchi, P, et al. Human bone marrow non-B, non-T cells produce interleukin-4 in response to cross-linkage of Fcɛ and Fcγ receptors. Proc Natl Acad Sci U S A 1991: 88: 8656–60. 83 Pin, I, Gibson, PG, Kolendowicz, R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992: 47: 25–9. 84 Pipkorn, U, Proud, D, Lichtenstein, LM, et al. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest 1987: 80: 957–61. 85 Plaut, M, Pierce, JH, Watson, CJ, Hanley, HJ, Nordan, RP, Paul, WE. Mast cell lines produce lymphokines in response to cross-linkage of fcɛRI or to calcium ionophores. Nature 1989: 339: 64–7. 86 Sampson, D, Archer, GT. Release of histamine from human basophils. Blood 1967: 29: 722–36. 87 Sampson, HA, Broadbent, KR, Bernhisel-Broadbent, J. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989: 321: 228–32. 88 Sanderson, CJ, Campbell, HD, Young, IG. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effect on human and mouse B cells. Immunol Rev 1988: 102: 29. 89 Schleimer, RP, Derse, CP, Friedman, B, et al. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. J Immunol 1989: 143: 1310–17. 90 Schleimer, RP, Lichtenstein, LM, Gillespie, E. Inhibition of basophil histamine release by antiinflammatory steroids. Nature 1981: 292: 454–5. 91 Schleimer, RP, Sterbinsky, SA, Kiser, J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. J Immunol 1992: 148: 1086–92. 92 Schroeder, JT, MacGlashan, DW JR, Kagey-Sobotka, A, White, JM, Lichtenstein, LM. Ige-dependent IL-4 secretion by human basophils: the relationship between cytokine production and histamine release in mixed leukocyte cultures. J Immunol 1994: 153: 1808–17. 93 Schulman, ES, MacGlashan, DW JR, Peters, SP, Schleimer, RP, Newball, HH, Lichtenstein, LM. Human lung mast cells: purification and characterization. J Immunol 1982: 129: 2662–7. 94 Schwartz, L, Huff, T. Biology of mast cells and basophils. In: E Middleton, CE Reed, EF Ellis, NF Adkinson, JW Yunginger, eds. Allergy: principles and practice. St Louis , MO : CV Mosby, 1992: 135–68. 95 Seder, RA, Paul, WE, Dvorak, AM, et al. Mouse splenic and bone marrow cell populations that express high affinity Fcɛ receptors and produce interleukin-4 are highly enriched in basophils. Proc Natl Acad Sci U S A 1991: 88: 2835–9. 96 Siraganian, RP, Hook, WA. Complement-induced histamine release from human basophils. II. Mechanism of the histamine release reaction. J Immunol 1976: 116: 639–46. 97 Siraganian, RP, Hook, WA. Mechanism of histamine release by formyl methionine containing peptides. J Immunol 1977: 119: 2078–83. 98 Solley, GO, Gleich, GJ, Jordan, RE, Schroeter, AL. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest 1976: 58: 408–20. 99 Sparrow, D, O'Connor, GT, Rosner, B, Weiss, ST. Predictors of longitudinal change in methacholine airway responsiveness among middle-aged and older men: the normative aging study. Am J Respir Crit Care Med 1993: 149: 919. 100 Subramanian, N, Bray, MA. Interleukin-1 releases histamine from human basophils and mast cells in vitro. J Immunol 1987: 138: 271–5. 101 Swain, SL, Weinberg, AD, English, M, Huston, G. IL-4 directs the development of Th2–like helper effectors. J Immunol 1990: 145: 3796–3806. 102 Thueson, DO, Speck, LS, Lett-Brown, MA, Grant, JA. Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol 1979: 123: 626–31. 103 Tomioka, M, Ida, S, Shindoh, Y, Ishihara, T, Takishima, T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis 1984: 129: 1000–5. 104 Tung, R, Lichtenstein, LM. In vitro histamine release from basophils of asthmatic and atopic individuals in D2O. J Immunol 1982: 128: 2067–72. 105 Valent, P. The riddle of the mast cell: kit(CD117)-ligand as the missing link Immunol Today 1994: 15: 111–14. 106 Valent, P, Besemer, J, Muhm, M, Majdic, O, Lechner, K, Bettelhein, P. Interleukin-3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci USA 1989: 86: 5542–6. 107 Van Der Donk, AMM, Blok, W, Mkok, PT, Bruijnzeel, PLB. Leukotriene C4 formation by enriched human basophil preparations from normal and asthmatic subjects. Prostaglandins Leukot Essent Fatty Acids 1991: 44: 11–17. 108 Vercelli, D, Geha, RS. Regulation of IgE synthesis in humans: a tale of two signals. J Allergy Clin Immunol 1991: 88: 285–95. 109 Vercelli, D, Jabara, HH, Arai, K-I, Geha, RS. Induction of human IgE requires interleukin-4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens. J Exp Med 1989: 169: 1295–1307. 110 Warner, JA, MacGlashan, DW Jr. signal transduction events in human basophils: a comparative study of the role of protein kinase-C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine. J Immunol 1990: 145: 1897–1905. 111 Warner, JA, Pienkowski, MM, Plaut, M, Norman, PS, Lichtenstein, LM. Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions. J Immunol 1986: 136: 2583–7. 112 Wodnar-Filipowicz, A, Heusser, CH, Moroni, C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989: 339: 150–2. 113 Zucker-Franklin, D. Ultrastructural evidence for the common origin of human mast cells and basophils. Blood 1980: 56: 534–40. Citing Literature Volume50, Issue6June 1995Pages 463-472 ReferencesRelatedInformation